179 related articles for article (PubMed ID: 28236172)
1. In-silico screening, identification and validation of a novel vaccine candidate in the fight against Plasmodium falciparum.
Panda SK; Mahapatra RK
Parasitol Res; 2017 Apr; 116(4):1293-1305. PubMed ID: 28236172
[TBL] [Abstract][Full Text] [Related]
2. Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparum.
Pritam M; Singh G; Swaroop S; Singh AK; Singh SP
BMC Bioinformatics; 2019 Feb; 19(Suppl 13):468. PubMed ID: 30717656
[TBL] [Abstract][Full Text] [Related]
3. In-silico structural modeling and epitope prediction of highly conserved Plasmodium falciparum protein AMR1.
Sanasam BD; Kumar S
Mol Immunol; 2019 Dec; 116():131-139. PubMed ID: 31648168
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel therapeutic candidates in Cryptosporidium parvum: an in silico approach.
Panda C; Mahapatra RK
Parasitology; 2018 Dec; 145(14):1907-1916. PubMed ID: 29692282
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
6. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
[TBL] [Abstract][Full Text] [Related]
7. Malaria vaccine based on self-assembling protein nanoparticles.
Burkhard P; Lanar DE
Expert Rev Vaccines; 2015; 14(12):1525-7. PubMed ID: 26468608
[TBL] [Abstract][Full Text] [Related]
8. Computational screening and characterization of putative vaccine candidates of Plasmodium vivax.
Nanda Kumar Y; Jeyakodi G; Gunasekaran K; Jambulingam P
J Biomol Struct Dyn; 2016 Aug; 34(8):1736-50. PubMed ID: 26338678
[TBL] [Abstract][Full Text] [Related]
9. In silico design of knowledge-based Plasmodium falciparum epitope ensemble vaccines.
Damfo SA; Reche P; Gatherer D; Flower DR
J Mol Graph Model; 2017 Nov; 78():195-205. PubMed ID: 29100164
[TBL] [Abstract][Full Text] [Related]
10. Immunoinformatics approach for multi-epitope vaccine design against P. falciparum malaria.
Maharaj L; Adeleke VT; Fatoba AJ; Adeniyi AA; Tshilwane SI; Adeleke MA; Maharaj R; Okpeku M
Infect Genet Evol; 2021 Aug; 92():104875. PubMed ID: 33905890
[TBL] [Abstract][Full Text] [Related]
11. Restricted T-cell epitope diversity in the circumsporozoite protein from Plasmodium falciparum populations prevalent in Iran.
Zakeri S; Avazalipoor M; Mehrizi AA; Djadid ND; Snounou G
Am J Trop Med Hyg; 2007 Jun; 76(6):1046-51. PubMed ID: 17556609
[TBL] [Abstract][Full Text] [Related]
12. A phase 1, randomized, controlled dose-escalation study of EP-1300 polyepitope DNA vaccine against Plasmodium falciparum malaria administered via electroporation.
Spearman P; Mulligan M; Anderson EJ; Shane AL; Stephens K; Gibson T; Hartwell B; Hannaman D; Watson NL; Singh K
Vaccine; 2016 Nov; 34(46):5571-5578. PubMed ID: 27697302
[TBL] [Abstract][Full Text] [Related]
13. In silico analysis and prediction of immunogenic epitopes for pre-erythrocytic proteins of the deadly Plasmodium falciparum.
Asghari A; Nourmohammadi H; Majidiani H; Shariatzadeh SA; Shams M; Montazeri F
Infect Genet Evol; 2021 Sep; 93():104985. PubMed ID: 34214673
[TBL] [Abstract][Full Text] [Related]
14. Positive-unlabeled learning identifies vaccine candidate antigens in the malaria parasite Plasmodium falciparum.
Chou RT; Ouattara A; Adams M; Berry AA; Takala-Harrison S; Cummings MP
NPJ Syst Biol Appl; 2024 Apr; 10(1):44. PubMed ID: 38678051
[TBL] [Abstract][Full Text] [Related]
15. Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda.
Kanoi BN; Takashima E; Morita M; White MT; Palacpac NM; Ntege EH; Balikagala B; Yeka A; Egwang TG; Horii T; Tsuboi T
Vaccine; 2017 Feb; 35(6):873-881. PubMed ID: 28089547
[TBL] [Abstract][Full Text] [Related]
16. Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen.
Dreyer AM; Matile H; Papastogiannidis P; Kamber J; Favuzza P; Voss TS; Wittlin S; Pluschke G
J Immunol; 2012 Jun; 188(12):6225-37. PubMed ID: 22593616
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics characterization of Plasmodium knowlesi apical membrane antigen 1 (PkAMA1) for multi-epitope vaccine design.
Azazi A; Haron FN; Chua KH; Lim YAL; Lee PC; Chew CH
Trop Biomed; 2021 Sep; 38(3):265-275. PubMed ID: 34362869
[TBL] [Abstract][Full Text] [Related]
18. Development of the RTS,S/AS malaria candidate vaccine.
Vekemans J; Leach A; Cohen J
Vaccine; 2009 Dec; 27 Suppl 6():G67-71. PubMed ID: 20006143
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
20. Vaccinating with the genome: a Sisyphean task?
Coppel RL
Trends Parasitol; 2009 May; 25(5):205-12. PubMed ID: 19359219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
